|
October
16,
2002 Issue 126
From
The Editor's Desk:
 Every
patient we see is suppose to get a foot exam, but how many of us take
the time to explain why? Dr.
Joseph M. Caporusso, DPM Clinical Associate, University of Texas overviews
“The
Diabetic Insenative Foot – from callous to amputation”
Diabetes
In Control is partnering with Biosafe Kids to distribute free and
low-cost A1c tests to underserved members of the diabetes
population through medical professionals.
Check out this weeks Tools for your Practice.
Dr.
Rosen
updates us on a possibly unlimited source of Islet cells:
Your
patient finally agrees to exercise and then their blood glucose levels
go haywire and they blame it on exercise and quit. If that has happened,
you need to read Kristina
Sandstedt’s Meal
Planning and Exercise for Diabetes Patients
If
you need more reasons to teach the importance of exercise to your
patients then check out Item#12 to learn how “Exercise
Cuts Cardiovascular Risk Associated With Diabetes”
Watch
for a new diabetes treatment, approved by the FDA for type 2 diabetes, Avandamet,
see item #5
Don’t
miss item #8 as the controversy continues: “High
Protein Diet Helps Control Blood Glucose”
Check
to see if your name is listed on the winner’s page. All
Unclaimed prizes after this week will be redrawn for.
If you have already notified us your prizes will be going out this week.
Consider
making Diabetes in Control Your home page. (IE Users)
Dave Joffe, Editor-in-Chief
Steve Freed, Publisher
News
Flash - News Flash
UPDATE:
FDA
Approves New Indication for Glucovance
Glucovance
OK’ed to use with Thiazolidediones, which makes it a triple therapy.
Drugmaker
Bristol-Myers Squibb Company said on Friday that it received a
supplementary approval from the US Food and Drug Administration (FDA),
allowing the use of its type 2 diabetic therapy Glucovance (glyburide
and metformin HCl) along with thiazolidinediones (TZDs), such as Avandia
(rosiglitazone) and Actos (pioglitazone).
See item #6 below for more information.
1.
1 in 4 Type 2 Diabetes Patients Have Heart Disease With No Symptoms!
Click
Here
2.
Acidic Drinking Water May Increase Risk of Type 1 Diabetes
Click
Here
3.
Simvastatin Protects against Endothelial Dysfunction in Type 2 Diabetes
Click
Here
4.
Aggressive Management Key to Rapid Recovery for Diabetic Ketoacidosis
Click
Here
5.
FDA Approves GSK's Avandamet™ for Type 2 Diabetes Treatment*
Click
Here
6.
FDA Approves New Indication for Glucovance
Click
Here
7.
Obesity Rates Continue to Rise in US, As Does Diabetes*
Click
Here
8.
EASD: High Protein Diet Helps Control Blood Glucose in Untreated Type 2
Diabetics*
Click
Here
9.
Modulation of Post-operative Insulin Resistance by Pre-operative Carbohydrate
Loading Improves Outcomes
Click
Here
10.
Insulin Resistance Best Predictor of Diabetic Nephropathy
Click
Here
11.
Flexible Insulin Management Improves Quality of Life in Diabetes
Click
Here
12.
Exercise Cuts Cardiovascular Risk Associated With Diabetes
Click
Here
13.
Fish Oil Reduces Cholesterol in Diabetes Patients
Click
Here
14.
Glipizide GITS Has Advantages Over Other Second-Generation Sulfonylureas
Click
Here
15.
Low-Income Childhood Linked to Later Diabetes and Heart Disease Risks*
Click
Here
Product
Update
A1cNow
is Less Than 9 Dollars!
Now
less than 9 dollars for the first and only NGSP A1c test that is
instant and disposable.
For more info on how you can now use it in your office practice
Click Here
75%
of patients with diabetes are not getting the recommended A1c testing.
Packed
with Many Valuable Features... you'd
expect to pay over $2000.00 for a Website
Like This...
See
Examples, and Learn More.....>Click
Here
|
SUBSCRIBE |
|
|
|
NEWS
FLASH
!!!
|
|
 Drug
Card
Program
for
Seniors
Raises
Drug
Costs
Firms,
Agency
Clash
Over
Pricing
Law.
A
widely
advertised
discount
drug
program
for
Medicare
patients
abruptly
raised
its
prices
for
thousands
of
users
this
week.
Drug
giants
Bristol-Myers
Squibb
Co.
and
GlaxoSmithKline
PLC,
two
of
the
seven
pharmaceutical
companies
that
created
the
program
to
ward
off
criticism
they
were
charging
seniors
and
disabled
people
too
much
for
drugs,
said
yesterday
that
they
were
forced
to
reduce
some
of
their
discounts
in
the
Together
Rx
program
to
comply
with
a
federal
drug-pricing
law.
Read
More...
|
|
FDA Approves GSK's Avandamet™ for Type 2 Diabetes
Treatment 
